Online Courses
Aligning Treatment Goals and Value-Based Care in Newly Diagnosed Multiple Myeloma
CPE
Free
Learn More
Managing Immune-Related Adverse Events to Ensure Optimal Cancer Immunotherapy Outcomes: The Nurse’s View
ILNA | Pharmacotherapy | NCPD
Free
Learn More
Virtual Tumor Board: Multidisciplinary Management of Advanced Soft Tissue Sarcoma
CME | NCPD | MOC | ILNA | Pharmacotherapy
Free
Learn More
Pathology and Oncology Expert Perspectives in the Management of Triple-Negative Breast Cancer
CME | NCPD | MOC | ILNA | Pharmacotherapy
Free
Learn More
Leveraging the Growing Arsenal of Adjuvant Therapies for Early-Stage NSCLC
ILNA | CME | Pharmacotherapy | NCPD | MOC
Free
Learn More
Current Standards and New Directions in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura
ILNA | CME | Pharmacotherapy | NCPD | MOC
Free
Learn More
Hitting the Target in HER2-Positive Metastatic Colorectal Cancer
CME | NCPD | MOC | ILNA | Pharmacotherapy
Free
Learn More
Exploring New Treatment Advances for Acid Sphingomyelinase Deficiency in Adults
CME | NCPD | MOC
Free
Learn More
Virtual Tumor Board: Building Comprehensive Care Plans in Esophagogastric Cancers
CME | NCPD | MOC | ILNA | Pharmacotherapy
Free
Learn More
Expert Guidance on Current Standards and New Directions in Newly Diagnosed Multiple Myeloma
CME | MOC
Free
Learn More
Recurrent and Metastatic HNSCC: New Insights and Real-World Evidence for Improved Patient Outcomes
CME | NCPD | MOC | ILNA
Free
Learn More
Leveraging BCMA-Directed Therapies for Improved Patient Outcomes in Relapsed/Refractory Multiple Myeloma
CME | MOC
Free
Learn More
Cracking the Code for Improved Patient Outcomes in Advanced Renal Cell Carcinoma
CME | MOC
Free
Learn More
Novel Breast Cancer Therapies: Monoclonal Antibodies
CME | NCPD | MOC | CPE | ILNA | Pharmacotherapy
Free
Learn More
Novel Breast Cancer Therapies: Antibody-Drug Conjugates
CME | NCPD | MOC | CPE | ILNA | Pharmacotherapy
Free
Learn More
Novel Breast Cancer Therapies: PARP Inhibitors
CME | NCPD | MOC | CPE | ILNA | Pharmacotherapy
Free
Learn More
Novel Breast Cancer Therapies: Immune Checkpoint Inhibitors
CME | NCPD | MOC | CPE | ILNA | Pharmacotherapy
Free
Learn More
Novel Breast Cancer Therapies: CDK Inhibitors
CME | NCPD | MOC | CPE | ILNA | Pharmacotherapy
Free
Learn More
Novel Breast Cancer Therapies: PI3K Inhibitors
CME | NCPD | MOC | CPE | ILNA | Pharmacotherapy
Free
Learn More
Novel Breast Cancer Therapies: HER2 Tyrosine Kinase Inhibitors
CME | NCPD | MOC | CPE | ILNA | Pharmacotherapy
Free
Learn More
